RPL31P60

Across TCGA patient cohorts, RPL31P60 RNA expression is significantly associated with the go_rna of many other GO terms, with 6,423 significant associations in total. STAD shows the largest number of these associations.

The most reproducible RPL31P60-associated GO terms across cancer lineages are Somatic diversification of immunoglobulins, Peptidyl-lysine modification, and Immune system development. Each is linked with RPL31P60 in more than 17 cancer types. Because this analysis shows association rather than direction, both RPL31P60-to-partner and partner-to-RPL31P60 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, Somatic diversification of immunoglobulins grouped by RPL31P60-low versus RPL31P60-high in ESCA.

RNA expression associated GO terms by consensus

Ranked by combined sampling and lineage consensus. X-score (RPL31P60→partner) and Y-score (partner→RPL31P60) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner GO term	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
ESCA	Somatic diversification of immunoglobulins →	+0.053	+0.229	<.001	<.001	3	18
ESCA	Peptidyl-lysine modification →	+0.057	+0.263	<.001	<.001	3	17
STAD	Immune system development →	+0.058	+0.183	<.001	<.001	3	17
STAD	Positive regulation of DNA recombination →	+0.055	+0.198	<.001	<.001	3	17
STAD	Negative regulation of TORC1 signaling →	+0.060	+0.161	<.001	<.001	3	17
STAD	Organelle fusion →	+0.055	+0.159	<.001	<.001	3	17

Each partner links to its Q-omics profile. Showing the 6 strongest of 6,423 associations by consensus.

Somatic diversification of immunoglobulins by RPL31P60 expression — ESCA

Explore this box plot interactively →